Abstract:Studies in neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease and Amyotrophic lateral sclerosis, Huntington's disease, and so on, have suggested that inflammation is not only a result of neurodegeneration but also a crucial player in this process. Protein aggregates which are very common pathological phenomenon in neurodegeneration can induce neuroinflammation which further aggravates protein aggregation and neurodegeneration. Actually, inflammation even happens earlier than protein aggregation. Neuroinflammation induced by genetic variations in CNS cells or by peripheral immune cells may induce protein deposition in some susceptible population. Numerous signaling pathways and a range of CNS cells have been suggested to be involved in the pathogenesis of neurodegeneration, although they are still far from being completely understood. Due to the limited success of traditional treatment methods, blocking or enhancing inflammatory signaling pathways involved in neurodegeneration are considered to be promising strategies for the therapy of neurodegenerative diseases, and many of them have got exciting results in animal models or clinical trials. Some of them, although very few, have been approved by FDA for clinical usage. Here we comprehensively review the factors affecting neuroinflammation and the major inflammatory signaling pathways involved in the pathogenicity of neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Amyotrophic lateral sclerosis. We also summarize the current strategies, both in animal models and in the clinic, for the treatment of neurodegenerative diseases.

Histamine and receptors in neuroinflammation: Their roles on neurodegenerative diseases

Classical HDACs in the Regulation of Neuroinflammation.

Histamine in the Crosstalk Between Innate Immune Cells and Neurons: Relevance for Brain Homeostasis and Disease

The Role in Neurodevelopmental and Neurodegenerative Disorders

The Histaminergic System in Neuropsychiatric Disorders

Tackling Neuroinflammation in Cognitive Disorders with Single-Targeted and Multi-Targeted Histamine H3 Receptor Modulators

Role of histamine and its receptors in cerebral ischemia.

The modulatory role of dopamine receptors in brain neuroinflammation

Role of neuroinflammation in neurodegenerative diseases (Review).

Role of Neuroinflammation in Neurodegenerative Diseases (Review)

Targeting Microglia in Neuroinflammation: H3 Receptor Antagonists as a Novel Therapeutic Approach for Alzheimer's Disease, Parkinson's Disease, and Autism Spectrum Disorder

Histamine and histamine receptors: Roles in major depressive disorder

Targeting Histamine and Histamine Receptors for Memory Regulation: An Emotional Perspective

Role of histaminergic system in blood-brain barrier dysfunction associated with neurological disorders

Role of neuroinflammation in neurodegeneration development

Neuroinflammation of Microglial Regulation in Alzheimer's Disease: Therapeutic Approaches

Research progress on the role and regulatory mechanism of pathogenic Th17 cells in neuroinflammation

Histamine: A Key Neuromodulator of Memory Consolidation and Retrieval

Histamine receptors, agonists, and antagonists in health and disease

The role of neuroinflammation in neurodegenerative diseases: current understanding and future therapeutic targets

Histamine, histamine receptors, and neuropathic pain relief